ITCC-101/APAL2020D: A Randomized Phase 3 Trial of Fludarabine/Cytarabine/Gemtuzumab Ozogamycin with or without Venetoclax in Children with Relapsed Acute Myeloid Leukemia
Autor: | Ishimaru, Sae *, Gueguen, Gwenaëlle *, Karol, Seth E. *, Bautista Sirvent, Francisco J. *, Ceolin, Valeria *, Goemans, Bianca F., Bakker, Marlous *, Laurenzio, Laura Di *, Lukin, Jennifer *, Van Tinteren, Harm *, Sunkersett, Gauri B. *, Onishi, Maika, Unnebrink, Kristina *, Reinhardt, Dirk, Nichols, Gwen L, Kolb, E. Anders, Zwaan, C. Michel * |
---|---|
Zdroj: | In Blood 15 November 2022 140 Supplement 1:3369-3370 |
Databáze: | ScienceDirect |
Externí odkaz: |